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Abstract
Background: Migration of T cells, including regulatory T (Treg) cells, into the secondary lymph organs is critically controlled
by chemokines and adhesion molecules. However, the mechanisms by which Treg cells regulate organ-specific
autoimmunity via these molecules remain unclear. Although we previously reported autoimmune exocrinopathy
resembling Sjo ¨gren’s syndrome (SS) in the lacrimal and salivary glands from C-C chemokine receptor 7 (CCR7)-deficient
mice, it is still unclear whether CCR7 signaling might specifically affect the dynamics and functions of Treg cells in vivo.W e
therefore investigated the cellular mechanism for suppressive function of Treg cells via CCR7 in autoimmunity using mouse
models and human samples.
Methods and Findings: Patrolling Treg cells were detected in the exocrine organs such as lacrimal and salivary glands from
normal mice that tend to be targets for autoimmunity while the Treg cells were almost undetectable in the exocrine glands
of CCR7
2/2 mice. In addition, we found the significantly increased retention of CD4
+CD25
+Foxp3
+ Treg cells in the lymph
nodes of CCR7
2/2 mice with aging. Although Treg cell egress requires sphingosine 1-phosphate (S1P), chemotactic function
to S1P of CCR72/2 Treg cells was impaired compared with that of WT Treg cells. Moreover, the in vivo suppression activity
was remarkably diminished in CCR7
2/2 Treg cells in the model where Treg cells were co-transferred with CCR7
2/2
CD25
-CD4
+ T cells into Rag2
2/2 mice. Finally, confocal analysis showed that CCR7
+Treg cells were detectable in normal
salivary glands while the number of CCR7
+Treg cells was extremely decreased in the tissues from patients with Sjo ¨gren’s
syndrome.
Conclusions: These results indicate that CCR7 essentially governs the patrolling functions of Treg cells by controlling the
traffic to the exocrine organs for protecting autoimmunity. Characterization of this cellular mechanism could have clinical
implications by supporting development of new diagnosis or treatments for the organ-specific autoimmune diseases such
as Sjo ¨gren’s syndrome and clarifying how the local immune system regulates autoimmunity.
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Introduction
Emerging evidence demonstrates that CD4
+CD25
+Foxp3
+
regulatory T cells (Treg cells) play a central role in the protection
of autoimmunity [1–3]. Treg cells actively suppress pathological
and physiological immune responses, contributing to the mainte-
nance of immunological self-tolerance and immune homeostasis.
However, it has not been clarified whether the ability of Treg cells
to migrate among tissues is important for them in exerting their
suppressor function. On the other hand, recent reports showed
that Treg cells are also present within non-lymphoid sites in the
periphery, including autoimmune lesions, infectious sites, and
tumors [4]. The depletion of Treg cells from normal mice leads to
spontaneous development of various autoimmune diseases, such
as autoimmune thyroiditis, type 1 diabetes, gastritis, and inflam-
matory bowel disease [5–8]. Although the injection of Treg cells
into animal models for autoimmunity can prevent or reduce the
onset of diseases [9–11], it is still unclear which sites of Treg cells
can display their function in vivo. In a model of type I diabetes,
NOD mice, the disease resistance has been correlated with the
expansion of Treg cells within inflamed pancreatic lymph nodes
[12]. Moreover, it was demonstrated that the number of Treg
cells increased in the lamina propria of inflamed tissues from
patients with inflammatory bowel disease (IBD) while the number
of Treg cells is significantly reduced in the peripheral blood
mononuclear cells (PBMCs) from the patients [8,13,14]. Although
various molecular and cellular events have been described to
explain the mechanisms of Treg-mediated suppression [15,16],
none of the proposed mechanisms can explain all aspects of in vivo
suppression.
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in the trafficking of Treg cells to lymphoid and non-lymphoid sites,
the participation of chemokine receptors has been demonstrated
by several studies [17–19]. Recent studies suggest that C-C-
chemokine receptor 7 (CCR7) and its ligands are involved in the
migration of naive T cells into the lymph nodes (LNs) and play an
important role in the initiation of adaptive immune responses
[20–24]. It has been shown that Treg cells can change their
chemotactic behavior by switching the expression of CXCR5 and
CCR7 in response to the ligands, CXCL13 and CCL19
respectively [25]. Previously we reported that autoimmune
exocrinopathy resembling Sjo ¨gren’s syndrome (SS) developed in
CCR7
2/2 mice [26]. In addition, it was indicated that enhanced
immunity in CCR7
2/2 mice is caused by the defective lymph node
positioning of Treg cells and the consequent impediment of the
suppressor function [23]. However, it is still unclear whether
CCR7 signaling might specifically affect the dynamics and
functions of Treg cells in vivo. We thus examined the role of
CCR7 signaling in the in vivo function of Treg cells that regulate
the development of autoimmunity.
Results
Patrolling Treg Cells in the Exocrine Glands
We have reported that the onset of autoimmune lesions in
lacrimal and salivary glands of CCR7
2/2 mice was at around 10
weeks of age [26]. It is still unclear whether Treg cells infiltrate
into tissues which include the lacrimal or salivary glands as the
target organs in CCR7
2/2 mice. Therefore, we tested for tissue-
infiltrating Treg cells in various tissues including lacrimal,
salivary glands, lung, liver, kidney and colon of WT and
CCR7
2/2 mice using flow cytometric analysis with Foxp3
expression. Interestingly, the Treg cells within the lacrimal and
salivary glands of CCR7
2/2 mice were significantly decreased in
comparison with those of WT mice (Fig. 1A and B). By contrast,
there was no difference in the Treg cells within the other organs
between WT and CCR7
2/2 mice (Fig. 1B). When immunoflu-
orescence staining with anti-CD4 and Foxp3 mAbs was
performed using frozen sections of the salivary and lacrimal
glands from WT and CCR7
2/2 mice, Foxp3
+CD4
+ Treg cells
were found in the lacrimal and salivary gland tissues from
normal WT mice although the cell number was lower (Fig. 1C
and D). To the contrary, Foxp3
+ Treg cells were almost
undetectable in the lacrimal and salivary gland tissues of
CCR7
2/2 mice (Fig. 1C and D). Thus, the presence of
‘‘patrolling’’ Treg cells within tissues such as the lacrimal and
salivary glands is associated with the maintenance of peripheral
tolerance to protect autoimmunity.
Treg Cells in the Lymphoid Tissues of CCR7
2/2 Mice
In order to examine the basis for the decreased number of Treg
cells in the target organs of autoimmunity in CCR7
2/2 mice, Treg
Figure 1. Tissue Distribution of Treg Cells. (A) Flow cytometric analysis of Foxp3
+CD4
+ T cells in tissue-infiltrating lymphocytes was performed
using lacrimal, salivary glands, and lung of WT and CCR7
2/2 mice. (B) Foxp3
+CD4
+ Treg cells (%) were shown using lacrimal, salivary glands, lung, liver,
kidney, and colon from WT and CCR7
2/2 mice. Data are means6s.e.m. of 3 to 4 mice per each group. *p,0.05, **p,0.005, versus WT. (C and D)
Foxp3
+CD4
+Treg cells were detected on the frozen sections of lacrimal and salivary glands from WT and CCR7
2/2 mice. Upper photos show histology
stained with H&E. Foxp3 and CD4 are shown as green and red. Nuclei were stained with DAPI (blue). Results are representative of 3 to 4 mice per each
group.
doi:10.1371/journal.pone.0008588.g001
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2/2 mice were
compared using flow cytomtric analysis. Although the absolute
number of T cells in the spleen and lymph nodes (LNs) from
CCR7
2/2 mice was found to be significantly decreased compared
with that from WT mice as previously described [23], a significant
increase in CCR7
2/2 Treg cell retention with aging was observed
in LNs, not in the spleen (Fig. 2A). The population of Foxp3
+ cells
(%) among CD4
+ cells in LNs of CCR7
2/2 mice was found to be
significantly increased compared with that of WT mice while the
population was significantly decreased in the spleen (Fig. 2A and
B). There was no difference of Foxp3
+ cells (%) in PBMCs and
thymocytes between CCR7
2/2 and WT mice (Fig. 2B). In
addition, an increase in Foxp3
+CD4
+Treg cells in the cervical
LNs (cLN) of CCR7
2/2 mice was observed, in comparison with
that in WT cLNs at 6-months-old (Fig. 2C). On the other hand,
CD25
2CD4
+ T cells from CCR7
2/2 mice were not accumulated
both in spleen and cLNs (Fig. S1). These findings suggest that the
impaired traffic of CCR7
2/2 Treg cells from the regional lymph
nodes to target organs of autoimmunity influences the develop-
ment of organ-specific autoimmunity.
Figure 2. Change of Treg Cells with Aging in Spleen and LNs of CCR7
2/2 Mice. (A) The number of Foxp3
+CD4
+ T cells in spleen and LNs from
WT and CCR7
2/2 mice from 2 to 6 months of age was analyzed by flow cytometer. Data are means6s.e.m. of 7 to 10 mice in each group. *p,0.05,
versus the cell number at 2 mo (upper panel), *p,0.05, **p,0.005, versus WT. (B) Foxp3 expressions of CD4
+ T cells in PBMC, spleen, LNs, and thymus
from WT and CCR7
2/2 mice at 2 and 6 months of age were analyzed by flow cytometer. (C) CD4
+Foxp3
+ cells in cervical lymph node were analyzed
by confocal microscopy. Figures and photos are representative of 3 to 7 mice in each group.
doi:10.1371/journal.pone.0008588.g002
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2/2 Treg Cells
It is unclear whether the in vivo homing of CCR7
2/2 Treg cells
to LNs is impaired. To examine the in vivo movement of Treg cells,
Treg cells from CCR7
2/2 mice were co-transferred with WT
green fluorescence protein (GFP)-transgenic (Tg) Treg cells into
Rag2
2/2 mice. We found the significantly increased accumulation
of CCR7
2/2 Treg cells in the lymph nodes compared with WT
Treg cells (Fig. 3A), indicating that the absence of CCR7 on Treg
cells may influence the egress from LNs rather than the homing to
LNs.
On the other hand, T cell egress from the thymus and
peripheral lymphoid organs depends on sphingosine 1-phosphate
(S1P) receptor-1 (S1P1) signaling, and is thought to occur in
response to circulatory S1P [27–30]. Although recent work has
shown that S1P is required for induction of egress [31,32], the
mechanism by which S1P1 acts to regulate the traffic of Treg cells
has been unclear. To examine whether the egress of CCR7
2/2
Treg cells from LNs is impaired, in vitro migration assay to S1P or
CCR7’s ligands using a boyden chamber with polyethylene
terephthalate membrane was performed. We found that CD3-
engaged LN Treg cells in CCR7
2/2 mice could not migrate to
S1P, while Treg cells from WT mice efficiently migrated to S1P
upon CD3 engagement (Fig. 3B). When the ligand of CCR7,
CCL19 or CCL21, was added to the culture of CD3-engaged
Treg cells with or without S1P, the migratory responses of WT
Treg cells were highly enhanced compared with the responses of
CCR7
2/2 Treg cells (Fig. 3B). In contrast, the migration activity to
S1P upon CD3 engagement of CCR7
2/2 non-Treg cells was
equivalent to that of WT non-Treg cells (Fig. 3C). These results
indicate that CCR7 crucially regulates the egress of Treg cells
from the LNs.
Impaired In Vivo Suppressive Function of CCR7
2/2 Treg
Cell
In order to evaluate the function of CCR7
2/2 Treg cells in vivo,
we transferred Treg cells from CCR7
2/2 and WT mice into mice
that exhibited inflammatory lesions in lacrimal and salivary glands
resembling SS by the transfer of CCR7
2/2 CD25
2CD4
+ LN T
cells into Rag2
2/2 mice (Fig. 4A and B). Upon the co-transfer of
WT Treg cells, the lesions of lacrimal glands were clearly
prevented (Fig. 4A and B). However, the co-transfer of CCR7
2/2
Treg cells did not prevent the autoimmune lesions (Fig. 4A and B).
We also found that the number of Foxp3
+CD4
+Treg cells was
increased in cervical lymph nodes (cLNs) but not the spleen of
Rag2
2/2 mice transferred with CCR7
2/2 Treg cells compared
with those transferred with WT Treg cells (Fig. 4C and D). These
results suggested that CCR7 expression on Treg cells influence
the in vivo mechanism for the development of autoimmune
exocrinopathy.
CCR7
+ Treg Cells in the Human Target Organ
To examine whether the patrolling Treg cells are observed in
human salivary gland tissues, CCR7
+Foxp3
+ Treg cells of the
salivary glands from controls and SS patients were analyzed using
sections of lip biopsy samples. The histopathological finding of
salivary gland tissues from patients with SS showed the destruction
or atrophy of acinar cells, and lymphocyte infiltration around ductal
cells while there was no inflammation in the tissues from controls
(Fig. 5A). However, a small number of lymphocytes were detectable
in the stromal tissue of salivary glands from controls (Fig. 5A). The
major population of infiltrating immune cells in the salivary gland
tissues from SS patients was CD4
+ T cell (Fig. 5B). Although the cell
number of lymphocyte in control tissues was considerably lower, a
Figure 3. Homing and Egress of CCR7
2/2 Treg Cells. (A) CCR7
2/2
Treg cells (1610
6) and WT GFP-Tg Treg cells (1610
6), or CCR7
2/2
CD25
-CD4
+ and WT CD25
-CD4
+ cells were co-transferred into Rag2
2/2
mice. At 2 weeks later CD4
+ GFP
2 cells (from CCR7
2/2 mice) or CD4
+
GFP
+ cells (from WT mice) in LNs of the recipient Rag2
2/2 mice were
detected by flow cytometry. Results are representative of five to seven
mice in each group. *p,0.05, **p,0.005, versus WT. (B) Migration assay
of Treg cells from LNs of WT and CCR7
2/2 mice was performed with
anti-CD3 mAb, S1P, CCL19 and CCL21. Data are means6s.e.m. of
triplicate and are representative of three independent experiments.
*p,0.05, **p,0.005, versus WT.
doi:10.1371/journal.pone.0008588.g003
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+ T cells were detectable (Fig. 5B). In addition,
CCR7
+Foxp3
+ Treg cells were detectable in the connective tissue
and around the acinar or ductal cells of control salivary glands while
the cells were hardly detected among the inflammatory lesions of SS
patients (Fig. 5C). Approximately 40,50% cells among infiltrating
immune cells in the salivary glands from SS patients was CD4
+ as
shown in Figure 5A. The reduction of Treg cell number in the
salivary glands from SS patients seemed to be not related to an
overall reduction of CD4
+ T cells. When the cell number of
CCR7
+Foxp3
+ Treg cells in the control samples was comparedwith
that from SS patients, the number of controls (3.7061.34/mm
2)
was significantly increased than that of SS patients (1.1861.16/
mm
2) (Fig. 5D). The reduction of Treg cell number in the salivary
glands from SS patients seemed to be not related to an overall
Figure 4. Disorder of In Vivo Regulatory Function of Treg Cells in CCR7
2/2 Mice. (A) WT or CCR7
2/2 CD25
2CD4
+ T cells (5610
6) were
transferred into Rag2
2/2 mice. WT or CCR7
2/2 Treg cells (2.5610
6) were co-transferred with CCR7
2/2 CD25
2CD4
+ T cells (5610
6) into Rag2
2/2 mice.
At 6 week after the transfer all organs were histopathologically analyzed. Pathology of lacrimal glands from the Rag2
2/2 recipient mice was shown
using the sections stained with hematoxylin and eosin. (B) Histological evaluation of inflammatory lesions in the recipient Rag2
2/2 mice. Data are
means6s.e.m. of 5 to 7 mice in each group. (C) Foxp3
+CD4
+ Treg cells in lymph nodes were detected by confocal analysis. (D) Foxp3 expression of
CD4
+ T cells in LNs and spleen was analyzed by flow cytometer. *p,0.05, **p,0.005, versus WT.
doi:10.1371/journal.pone.0008588.g004
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+Foxp3
2 cells
in the salivary gland tissues from SS patients were also found (Fig.
S2). However, the CCR7
+Foxp3
2 cells were hardly detectable in
the control tissues (data not shown). As it is known that CCR7 is
expressed on T cells and mature dendritic cells [33], the cells
expressing CCR7 in the inflamed salivary gland tissues from SS
patients may be dendritic cells or T cells other than Treg cells. This
finding showed that CCR7
+ Treg cells are patrolling within the
target organ such as salivary gland to protect human autoimmunity
as well as a murine model.
Discussion
Our previous report demonstrated that CCR7 plays an essential
role in the migration of thymocytes from the cortex to the medulla
in the thymus for maintaining central immune tolerance[26]. It was
suggested that mature thymocytes exported from the cortex in the
absence of CCR7 were potent in causing autoimmunity. We found
that the autoreactive T cells inducing autoimmune lesions in
CCR7
2/2 mice are generated in the thymus where positively
selected thymocytes including any autoreactive T cells are exported
from the cortex. However, it is still unclear how the autoimmunity is
caused by the disturbance in the peripheral immune system.
It is well known that lymphocyte egress from lymphoid organs is
essential for immunsurveillance [29,31,34]. In contrast to the
cascade of molecular interactions required for cell entry from
blood into tissues [35–37], the multistep requirements for
lymphocyte egress, in particular for Treg cells, have not been
defined. It has been demonstrated that Foxp3 plays an essential
role in suppressing AP-1 DNA-binding activity and consequently
inhibits AP-1 transcription activity, because expression of Foxp3
significantly blocked AP-1 transcription activity and promoter
DNA-binding [38]. In addition, it has been suggested that the
migratory capacity of Treg cells is controlled by distinct signals
from chemokines/chemokine receptors. Recent studies have
shown that CCR7 and CCR7 ligands are not only involved in
cell entry to lymphoid tissues but also promote T cell motility [38–
40]. Additionally, our finding as to the increased accumulation of
CCR7
2/2 Treg cells in the lymph nodes was different from the
report that transferred CCR7
2/2 Treg cells fail to migrate into the
lymph nodes and suppress antigen-induced T cell response [23].
In our experiment, the CCR7
2/2 Treg cells were transferred into
Rag2
2/2 mice which are lymphopenic while CCR7
2/2 Treg cells
bearing antigen-specific T cell receptor cells were transferred into
normal mice in the previous report [23]. It was indicated that the
phenotype and function of Treg cells were largely changed in the
lymphopenic condition compared with normal one [41,42]. It was
possible that the homing function of CCR7
2/2 Treg cells might be
altered in the lymphopenic condition.
As for the other T cells, CCR7
2/2 CD25
2CD4
+ T cells were
analyzed together with the Treg cells in this study. We observed no
retention of CCR7
2/2 CD25
-CD4
+ T cells in LNs. Thus, there are
some differences in the response via CCR7 between Treg and
CD25
2CD4
+ cells. On the other hand, the abnormal findings of
CCR7
2/2 Treg cells were observed in LNs, not in the spleen.
Levels of S1P and chemokines are different in the lymph nodes,
blood, and various tissues [32]. It is possible that the functions of
Treg cells may be dependent on the response to each level of S1P
or chemokines such as CCL19 and CCL21 through S1P1 or
CCR7. Moreover, a recent report demonstrated that CCR7-
mediated donor-derived antigen-presenting cell (APC) trafficking
to the draining LN is not only important in initiation of host T cell
priming, but also crucial for Treg-mediated tolerance [43].
Although our study has not focused on the role of CCR7 in
Figure 5. CCR7
+Treg Cells in the Human Salivary Gland Tissues.
(A) Histology of salivary gland tissues in SS patients. The sections of lip
biopsy from controls and SS patients were stained with H&E. Photos are
representative of 5 to 7 samples. (B) CD4
+ T cells in the salivary gland
tissues were detected by immunofluorescence staining. Nuclei were
attained with DAPI. Photos are representative of 7 to 10 samples. (C)
CCR7
+Foxp3
+ cells were detected in the frozen sections of salivary
glands from controls and SS patients. Photos are representative of 10 to
12 samples. (D) The cell number of CCR7
+Foxp3
+ cells in the salivary
gland tissues was evaluated. The results are shown as the number per
1m m
2 of the tissues from 10 controls and 12 SS patients. *p,0.05,
control versus SS.
doi:10.1371/journal.pone.0008588.g005
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+
dendritic cells, CD11b
+ macrophages, or B220
+ B cells were
detectable (data not shown). It is possible that CCR7 plays any
important roles in APC functions in immune responses.
When we analyzed cytokine secretions of CCR7
2/2 and WT
Treg cells including IL-4, IL-10, and TGF-b using the
supernatants from Treg cells stimulated by plate-coated anti-
CD3 and CD28 mAbs. There were no differences in the
concentration levels of the cytokines between CCR7
2/2 and WT
Treg cells. Moreover, we observed the in vitro, not in vivo,
suppression function of CCR7
2/2 Treg cells similar to WT Treg
cells as previously described [23].
Our hypothesis is that the egress of Treg from LNs into the target
organs is essentially required for a suppressive effect on autoimmu-
nity. When the Treg cells from the immune cells that had infiltrated
the lacrimal and salivary glands of WT mice were evaluated by flow
cytometric analysis and immunostaining, significantly increased
Foxp3
+TregcellsweredetectablecomparedwiththoseofCCR7
2/2
mice. The exocrine organs such as the lacrimal and salivary glands
tend to be target organs for autoimmunity in CCR7
2/2 mice. It is
possible thatfunctionalTregcellsmight bepatrollinginthe exocrine
glands such as the lacrimal and salivary glands to protect
autoimmunity in vivo. Recently, we reported that a significantly
decreased numberofTregcellswasfound inthelaminapropria(LP)
of intestinal mucosa tissues of a rat model for inflammatory bowel
disease compared with the Treg cell number in normal LP [44].
Thus, trafficking of Treg cells into inflammatory lesions could be
crucial for in vivo suppression of autoimmunity.Onthe other hand, it
was reported that antigen-specific Treg cells expanded in the
peripheral lymphoid compartment and readily accumulated in the
central nerve system, but not prevent the onset of the disease using
experimental autoimmune encephalomyelitis (EAE), an animal
model for multiple sclerosis [45]. Furthermore, it was described that
high proportions of Treg cells are also found in the islets of NOD
mice protected following various types of interventions [46].
Therefore, a lack of controlling autoimmunity may not always
correlate with the number of Treg cells in a target tissue.
The findings of target organ from human controls and SS
patients would potently support our hypothesis. The trafficking
receptors on human Treg cells including CCR7 are controlled at
each differentiation stage in secondary lymphoid tissues [47]. It
was described that CD25
+CCR7
+CD62L
+CTLA-4
+Foxp3
+ cell is
one of peripheral circulating compartments of natural naı ¨ve CD4
+
Treg cells [48]. In addition, our result as for human Treg cells was
consistent with the previous report that CD25
highCD4
+T cells are
markedly diminished in the PBMCs and salivary gland tissues
from SS patients [49]. Although it is still unclear whether the
CCR7
+Foxp3
+ Treg cells in the normal salivary glands are natural
naı ¨ve Treg cells, the decreased cell number in SS patients suggests
that the expression of CCR7 on Treg cells may play a key role in
the protection of autoimmunity.
Our data provided the first evidence of an indispensable role of
CCR7 on Treg cell egress from the lymph nodes. Together,
CCR7-expressing Treg cells within the target tissue may control
the organ-specific self-tolerance to prevent autoimmunity in the
periphery. Moreover, analyzing the unique character of Treg cells
would help the establishment of the new diagnosis or therapeutic
strategy for human autoimmunity.
Materials and Methods
Ethics
This study was conducted according to the principles expressed
in the Declaration of Helsinki. The study was approved by the
Institutional Review Board of the University of Tokushima and
Tokushima University hospital (toku09021). All patients provided
written informed consent for the collection of samples and
subsequent analysis.
Mice
CCR7
2/2, CCR7
+/2, CCR7
+/+, Rag2
2/2, GFP-transgenic mice,
and C57BL/6 mice were reared in our specific pathogen-free
mouse colony, and given food and water ad libitum.
Histological Analysis
All organs were removed from the mice, fixed with 4%
phosphate-buffered formaldehyde (pH 7.2) and prepared for
histological examination. Formalin-fixed tissue sections were
subjected to hematoxylin and eosin (H&E) staining.
Cell Preparation
Treg cells and CD25
2CD4
+ cells were enriched from lymph
nodes or spleen. In brief, CD4
+ cells were prepared using anti-
B220, CD8, MHC class II, and NK1.1 mAbs (eBioscience, San
Diego, CA) and Dynal magnetic beads (Invitrogen, Carlsbad, CA).
CD25
+CD4
+ or CD25
2CD4
+ cells were enriched using biotin-
conjugated anti-CD25 mAb, magnetic beads, and Dynal CEL-
Lection Biotin Binder kit (Invitrogen), or panning with purified
anti-CD25 mAb. The enriched CD25
+CD4
+ cells were confirmed
to be ,95% Foxp3
+. For flow cytometric analysis of tissue-
infiltrating lymphocytes, mice were perfused transcardially with
saline (0.9%) to remove intravascular peripheral blood lympho-
cytes. After various tissues were cut into small pieces, digested by
collagenase (500 U/ml) and hyaluronidase (300 U/ml), and
homogenized, the lymphocytes were purified by centrifugation
with ficoll-paque (CEDARLANE Laboratories LtD., Burlington,
NC).
Confocal Microscopic Analysis
Frozen sections of lymph nodes were fixed with 3% parafor-
maldehyde in PBS, and pre-blocked with 1% BSA-2.5% FCS in
PBS for 1 hour. Sections were stained with anti-mouse CD4 and
Foxp3 (eBioscience, San Diego, CA) mAbs, anti-human CD4
(DAKO Japan, Tokyo, Japan), anti-human CCR7 (Abcam,
Cambridge, MA or R&D Systems Inc., Minneapolis, MN) and
biotin-conjugated anti-human Foxp3 (e-Bioscience) mAbs for one
hour. After three washes in PBS, the sections were stained with
Alexa Fluor 568 donkey anti-rat IgG (H+L) (Invitrogen), Alexa-
Fluor 488 anti-goat IgG (H+L), Alexa-Fluor 568-conjugated
streptavidin as the second antibodies for 30 minutes and washed
with PBS. The nuclei were stained with 49,6-diamidino-2-
phenylindole (DAPI). The sections were visualized with a laser
scanning confocal microscope (Carl Zeiss, Gottingen, Gremany).
A6 3 61.4 oil DIC objective lens was used. Quick Operation
Version 3.2 (Carl Zweiss) for imaging acquisition and Adobe
Photoshop CS2 (Adobe System, San Jose, CA) for image
processing was used.
Flow Cytometric Analysis
Surface markers were identified by mAbs with BD FACSCant
flow cytometer (Beckman Coulter, Miami, FL). Rat mAbs of
fluorescein isothiocyanate (FITC)-, phycoerythin (PE)-, or PE-
Cy5-conjugated anti-CD4, and CD25, were used. Intracellular
Foxp3 expression with an Intracellular Foxp3 Detection kit
(eBioscience) was done according to the manufacturer’s instruc-
tions. The data were analyzed with FlowJo FACS Analysis
software (Tree Star).
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To determine chemotaxis by S1P, CCL19, or CCL21 of Treg
cells from WT and CCR7
2/2 mice, Cultrex 96 Well Cell
Migration Assay Kit (Trevige, Inc., Gaithersburg, MD) was used
in accordance with the manufacture’s instructions. Prior to
beginning assay, the cells were starved for 24 hours in the
serum-free medium, and incubated in RPMI 1640 without FCS in
the presence of S1P (0–100 nM), CCL19 (100 ng/ml), or CCL21
(100 ng/ml) with plate-coated anti-CD3 mAb (0.5 mg/ml) for 3–
12 h.
Human Samples
Immunostaining for CCR7 and Foxp3 was performed using lip
biopsy samples from human SS patients and controls. All samples
were obtained from the Tokushima University Hospital, Tokush-
ima, Japan. All patients with SS were female, had documented as
xerostomia and keratoconjunctivitis sicca, and fulfilled the criteria
of the Ministry of Health, Labour and Welfare of Japan for the
diagnosis of SS. All patients with SS had focus scores of greater
than 2 by the Greenspan grading in their lip biopsy and all tested
positive for autoantibodies against Ro. Analysis was performed
under the certification of the ethics board of Tokushima University
Hospital.
Statistical Test
The Student t test was used for statistical analysis. Values of
p,0.05 were considered as significant.
Supporting Information
Figure S1 Change of CD25-CD4
+ T cells of CCR7
2/2 mice.
The positive cells (%) of CD25-CD4
+ T cells in spleen and LNs
from WT and CCR7
2/2 mice were analyzed by flow cytomery
from 2 to 6 months of age. Data are means6s.d. of 6 to 8 mice per
each group.
Found at: doi:10.1371/journal.pone.0008588.s001 (0.05 MB
PDF)
Figure S2 CCR7
+Foxp3
+ cells in the salivary gland tissues from
SS patients. The expressions of CCR7 (red) and Foxp3 (green) of
the infiltrating cells were analyzed by immunofluorescence
staining. Nuclei were stained with DAPI. Representative photos
are shown. The arrow heads show CCR7
+ lymphocytes or
dendritic cells.
Found at: doi:10.1371/journal.pone.0008588.s002 (0.22 MB
PDF)
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